beis 68 management LLC

p.o. box 367
monsey, new york 10952

NYS Entity Status
ACTIVE

NYS Filing Date
SEPTEMBER 09, 2014

NYS DOS ID#
4633678

County
ROCKLAND

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - BEIS 68 MANAGEMENT LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Shareholders Demand More Drastic Shifts at Nestlé
    By STEPHANIE STROM - Tuesday Jun 27, 2017

    The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.

    Source: NYT > Home Page
  • Blink Health Ends Pact With Express Scripts for Lilly Insulin Price Discounts
    Tuesday Jun 13, 2017

    Blink Health LLC, a provider of consumer price discounts for prescription drugs, said it has terminated its relationship with Express Scripts Holding Co., a pharmacy-benefit manager that helped arrange the new price break for Lilly’s insulin.

    Source: The Wall Street Journal: U.S. Business
  • DataGravity Brings Behavior-Driven Data Management to Veeam Environments
    By Frank J. Ohlhorst - Friday May 19, 2017

    DataGravity for Availability joins DataGravity for Virtualization in the DataGravity data management suite.

    Source: Gigaom
  • The Pop-Up Employer: Build a Team, Do the Job, Say Goodbye
    By NOAM SCHEIBER - Wednesday Jul 12, 2017

    “Flash organizations,” modeled on filmmaking, find their way into fields like software and pharmaceuticals, assembling freelancers and then disbanding.

    Source: NYT > Home Page
  • Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal
    By Frank Vinluan - Thursday Jul 6, 2017

    Celgene wants a shot at a bigger slice of the global cancer drug market, and the company is turning to China to do it. Summit, NJ-based Celgene has reached a deal with BeiGene, based in Beijing, for rights to a cancer immunotherapy still in clinical trials. The deal announced late Wednesday calls for Celgene (NASDAQ: […]

    Source: Xconomy New York
beis 68 management llc monsey ny